Regardless of the underlying pathways however, it is quite likely that dapagliflozin can downregulate TH and GRK2 in the adrenal medulla, leading to a profound sympatholytic effect on this important component of the sympathetic nervous system during chronic human HF. The gene discussed is GRK2; the disease is hydrops fetalis.